Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avalo Therapeutics (AVTX) Raw Materials (2018)

Avalo Therapeutics (AVTX) has disclosed Raw Materials for 1 consecutive years, with $11392.0 as the latest value for Q4 2018.

  • For the quarter ending Q4 2018, Raw Materials changed N/A year-over-year to $11392.0, compared with a TTM value of $11392.0 through Dec 2018, changed N/A, and an annual FY2018 reading of $11392.0, changed N/A over the prior year.
  • Raw Materials was $11392.0 for Q4 2018 at Avalo Therapeutics.
  • Across five years, Raw Materials topped out at $11392.0 in Q4 2018 and bottomed at $11392.0 in Q4 2018.